Introduction to Liquid Biopsy in Ovarian Cancer Ovarian cancer remains one of the most lethal gynecological malignancies worldwide, primarily due to its asymptomatic nature in
Introduction The landscape of gynecologic oncology has historically been constrained by the limitations of conventional chemotherapy, particularly for patients who develop platinum-resistant disease. Says Dr. Scott
Introduction The landscape of gynecological oncology is undergoing a profound paradigm shift as traditional diagnostic methods, often reliant on invasive procedures and subjective histopathological assessments,
Introduction: The New Frontier in Ovarian Cancer Care Ovarian cancer remains one of the most challenging gynecologic malignancies due to late-stage diagnoses and high recurrence
Introduction The landscape of oncological diagnostics is undergoing a paradigm shift, moving away from invasive tissue-sampling methods toward minimally invasive molecular profiling. In the context
Introduction The management of ovarian cancer has long been characterized by a reliance on systemic platinum-based chemotherapy, which, while initially effective, frequently leads to the
Introduction The landscape of gynecological oncology is undergoing a profound transformation driven by the integration of artificial intelligence into diagnostic workflows. Says Dr. Scott Kamelle, uterine
Introduction The landscape of oncology has undergone a significant transformation with the advent of precision medicine, particularly in the context of advanced ovarian malignancies. Historically,
Introduction The landscape of uterine oncology has undergone a profound transformation in recent years, shifting from a traditional histomorphological classification to a sophisticated molecular-driven framework.
Introduction The landscape of gynecologic oncology is undergoing a paradigm shift driven by the emergence of next-generation antibody-drug conjugates (ADCs). Says Dr. Scott Kamelle, historically, patients